TG Therapeutics Inc (TGTX)
- Exchange
- NASDAQ
- Symbol
- TGTX
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
- Country
- USA
Stock price
At close: September 22, 2025
-
Open32.50
-
High35.07
-
Low32.29
-
Close34.97
-
Volume3,437,970
Financial ratios
Dec 31, 2024